Label Image (Lbl530023643)
Losartan Potassium
Product Images NDC 53002-3643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-3643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Losartan Fig1)
This appears to be a partial excerpt from a medical study on the medications Atenolol and Losartan Potassium, which includes a chart showing a study period of 66 months. The only quantifiable information given is an "Adjusted Risk Reduction" of 13%, but no context is provided to explain what this percentage refers to. Without further information, it is difficult to provide a clear description or interpretation of this text other than that it is related to medical research on these two drugs.*
Figure2 (Losartan Fig2)
Figure 3 (Losartan Fig3)
Figure-4 (Losartan Fig4)
This appears to be a comparison of efficacy between two treatments for an unidentified health condition. The percentage of patients with an event is shown for each treatment group, along with the risk reduction achieved by one treatment compared to the other. A statistical measure of significance (p-value) is also provided. The name of the condition and the details of the treatments are not available.*
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
